Click for the first part of the story
Click for the second part of the story
Click for the third part of the story
Click for the fourth part of the story
Click for the fifth part of the story
Click for the sixth part of the story
Click for the seventh part of the story
Click for the eighth part of the story
Click for the ninth part of the story
In today's instalment, we'll venture into a little theory again. The theory of how this disease (type one diabetes mellitus) develops and what it means for us going forward.
We already know that the disease is caused by an autoimmune reaction. The cause of this deviation in immune system function depends on genetic makeup, but the disease itself is triggered by external influences. Doctors speculate that the trigger might be a particular infection (mumps, rubella, coxsackie viruses, cytomegalovirus), but it could also be chemicals, stress or some other contributing factor. B lymphocytes then begin producing antibodies against the pancreas's own beta cells, and T lymphocytes destroy those same cells through their cytotoxic action.
At the root of the disorder are changes in the major histocompatibility system - the HLA system. The genes that determine the risk of this disorder are part of the HLA system located on the short arm of chromosome 6. The risk of DM1, or increased resistance to this disease, is usually rooted more deeply in the entire genotype, but as already mentioned, many factors play a part in the development of the disease.
As for the risk of DM1, the statistics say the following:
General population: 0,2 % (2 in a thousand)
Child of a mother with DM1: 5% (Every 20th child)
Child of a father with DM1: 7% (About every 14th child)
Child of two parents with DM1: (30%, so a one-in-three chance)
Sibling with DM1: 5% (Every 20th child)
Identical twin: 40%
From a statistical and epidemiological perspective, two factors are important: incidence and prevalence.
Incidence is a measure of new cases of a disease arising within a certain period, usually a year.
Prevalence is a measure of the total number of people with a disease in a certain area.
In the Czech Republic, these figures are collected by the Institute of Health Information and Statistics of the Czech Republic. The collected data show a clear trend towards increasing numbers of people with the disease.
As for DM1 here, incidence peaks between the ages of 13 and 15 and is approximately 25 per 100000 inhabitants. So one in every 4000. There are regional differences too: while Finland leads with 28,6 per 100000 inhabitants, Denmark, for example, has just 14, and Japan 0,8.
As for paediatric patients, the 2nd Department of Paediatrics at Charles University's 2nd Faculty of Medicine and Motol University Hospital maintains the Czech Registry of Children with Diabetes. This registry was established in 1989 and records data on children aged 0 - 14 completed years, which are processed as part of the European EURODIAB study.
At present, DM1 occurs in 0,1-0,2% of children in the Czech Republic - so the odds are 1:500-1000.
Another very unpopular statistic, which medical books include, unlike books for patients, is mortality - in other words, the death rate.
Mortality in DM1 is substantially higher than in the rest of the population. Statistics show that the median survival time after diagnosis is 36 years, and the average age of a patient is 49. This is mainly due to associated complications. In young people who have had diabetes for over 20 years, it is mainly diabetic nephropathy; in people over 40, death from cardiovascular causes.
Of course, the statistics include patients treated years ago using methods that were pretty prehistoric (by today's standards), when instead of glucose meters, people peed over a burner and so on. Another story altogether is patients who refuse treatment and cycle between going without insulin, ketoacidosis and hospital stays. When Sárinka was in hospital after her disease was detected, we had the honour of meeting some of these mule-headed teenage patients, who went off at night to indulge in sweet tea. So these suicidal types are included in the statistics too, and it still holds true that the better the control, the longer the life and the fewer the complications.
The last thing I should discuss in this chapter is the so-called Saint Vincent Declaration. Given that diabetes (all types) is among the most common chronic diseases of both childhood and adulthood, the World Health Organization and the International Diabetes Federation organised a conference on diabetes in Saint Vincent, Italy, in 1989. Representatives of doctors, scientists and politicians agreed on a number of goals intended to guide national governments towards creating conditions to improve the lives of patients with diabetes, and towards educating both patients and doctors (because the disease essentially affects every other medical specialty). Since then, the approach to patients has changed, and it is clear that the main emphasis is on education. What our government took from such a declaration and how it creates conditions for people with the disease is something I'll write about next time, in the chapter about how the Grim Reaper paid us a visit.
The story continues, as usual, on Monday at 16:35.
RIK wrote this when the original blog was being created; not all the information stands up against current knowledge.